Orthopedic devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Trauma Fixation devices are used for the treatment of fractures. GlobalData uses proprietary data and analytics to provide a comprehensive report on the trauma fixation devices market, including market shares of different players within China. Buy the latest report here.

Smarter leaders trust GlobalData


Premium Insights China Trauma Fixation Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the trauma fixation market in China was DePuy Synthes followed by Zimmer Biomet, Weigao Group, Stryker and Smith & Nephew.

Trauma Fixation devices provide support for aligning, stabilizing and immobilization of fractured bones. Trauma fixation devices are broadly classified into two types – Internal Fixators and External Fixators.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the trauma fixation devices market within China was expected to be over $200m in 2022.

For the latest complete market share analysis of trauma fixation device market in China, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.